CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer
N
Shared by NobleBlocks on Nov 1, 2016 • 12:00 AM UTC
Authors:
Shawn F. Johnson
,
Cristina Cruz
,
Ann Katrin Greifenberg
Research Assistant
AI chat, annotations, notes & similar papers
Finding related papers...
Discussions
(0)
No comments yet
Be the first to share your thoughts!
CDK12 Inhibition Reverses De Novo and Acquired PARP Inhibitor Resistance in BRCA Wild-Type and Mutated Models of Triple-Negative Breast Cancer | NobleBlocks
